Green Plains Completes Sale of Fleischmann’s Vinegar to Kerry Group
OMAHA, Neb., Nov. 28, 2018 (GLOBE NEWSWIRE) — Green Plains Inc. (NASDAQ:GPRE) today announced that it has completed the previously […]
TSX News -
Calian Health Diversifies Customers with Health Wins Valued at More than $10M
OTTAWA, Nov. 28, 2018 (GLOBE NEWSWIRE) — Calian Group Ltd. (TSX: CGY) reports that its health services team has further […]
Pascal Biosciences Expands Leadership Team to Support Strategic Advancement of Its Cannabinoid Based Programs
VANCOUVER, B.C. and SEATTLE, Nov. 28, 2018 (GLOBE NEWSWIRE) — Pascal Biosciences Inc. (TSX.V:PAS) (“Pascal” or the “Company”), a drug […]
BlueRush Announces Fiscal 2018 Year-End Financial Results
– Company’s key SaaS business posts increases in revenue and gross margins – TORONTO, Nov. 28, 2018 (GLOBE NEWSWIRE) — […]
Diplomat Selects Inovalon’s Specialty Pharmacy Platform
Nation’s Largest Independent Provider of Specialty Pharmacy Services to Leverage ScriptMed® Enterprise to Support Operations and Improved Patient Care BOWIE, […]
Mercer International Inc. Announces Plans to Issue $350 Million of Senior Notes in Private Offering
NEW YORK, Nov. 28, 2018 (GLOBE NEWSWIRE) — Mercer International Inc. (Nasdaq: MERC) (the “Company”) today announced that it intends […]
Two Securities Industry Veterans Join FTI Consulting’s Forensic Accounting & Advisory Services Practice
Enhancing the Firm’s Broker-Dealer Regulatory Governance and Disputes Expertise WASHINGTON, Nov. 28, 2018 (GLOBE NEWSWIRE) — FTI Consulting, Inc. (NYSE: […]
Moleculin Announces New Data Further Supporting Its Lead Drug for Treating Pancreatic Cancer
WP1732 shown to accumulate beneficially in pancreas HOUSTON, Nov. 28, 2018 (GLOBE NEWSWIRE) — Moleculin Biotech, Inc., (Nasdaq: MBRX) (“Moleculin” […]
AquaBounty appoints Sylvia Wulf as Chief Executive Officer
MAYNARD, Mass., Nov. 28, 2018 (GLOBE NEWSWIRE) — AquaBounty Technologies, Inc. (NASDAQ: AQB) (“AquaBounty” or the “Company”), a biotechnology company […]
Alliqua BioMedical to spin off and merge its Contract Manufacturing Business with TO Pharmaceuticals LLC to Create an Independent, Publicly Traded Company focused on Cannabinoid-Based Pharmaceutical Therapies
LANGHORNE, Pa., Nov. 28, 2018 (GLOBE NEWSWIRE) — Alliqua BioMedical, Inc. (Nasdaq: ALQA) and TO Pharmaceuticals LLC, a privately held […]
